RE: RE: Big things coming5 Aug 2020 16:03
Announcement on one of the compounds related COVID 19 or Big Pharma eye on chk1 as the market has noted the research update "Sareum Holdings plc (AIM: SAR), the specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases, is pleased to announce that encouraging results have been published for its small molecule dual tyrosine kinase 2 (TYK2) and Janus kinase 1 (JAK1)
inhibitors in disease model studies of systemic lupus erythematosus (SLE) by its collaborator, SRI International."
This will be rerated on next RNS and this will head north breaking 1p resistance to multiples IMO